Replacing Bone Marrow Diagnostics With Peripheral Blood Analysis in MPN Patients

Sponsor
Weizmann Institute of Science
Study ID
NCT07648433
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Myeloproliferative Neoplasm

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • PERIBLOOD-MPN — DIAGNOSTIC_TEST
    Observational intervation of cHSPCs

Study Details

The PERIBLOOD-MPN study aims to develop and validate a minimally invasive peripheral blood test using single-cell RNA sequencing to accurately diagnose and classify myeloproliferative neoplasms, potentially reducing the need for invasive bone marrow biopsies.

Key Dates

First listed
Jun 15, 2026
Start date
Oct 31, 2026
Status verified
Jun 2026
Primary completion
Jun 30, 2029
Completion
Jun 30, 2032

Study Design

Enrollment
500 participants (estimated)

Primary Outcome Measure

To development PERIBLOOD-MPN Diagnostic Test [ Time Frame: Three months following the PB sample ]

Central Contacts

Related Studies